Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 20 Apr 2026 for Ultragenyx Pharmaceutical Inc.. Read the official filing
Filing timeline
BuySaleErik Harris
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Erik Harris: trading record in brief
This profile gathers the share dealings of Erik Harris across 3 companies, led by Ultragenyx Pharmaceutical Inc., Denali Therapeutics Inc. and Rezolute, Inc. We count 17 filings; the first trade dates from 6 May 2021 and the latest from 16 April 2026.
On the market, this insider has only sold: 8 sales, €516k in total. Outside the open market, there are 9 share grants.
The latest filing, published on 20 April 2026, reports a share grant in Ultragenyx Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Erik Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
28,895 shares0Common StockSEC:0001193125-26-164267:0
11,643 shares0Common StockSEC:0001193125-26-089282:0
21,000 shares0Common SharesSEC:0000912282-25-001286:0
16,813 shares0Common StockSEC:0000950170-25-032773:0
5,967 shares0Common StockSEC:0001714899-24-000134:0
19,400 shares0Common StockSEC:0000950170-24-026629:0
6,000 shares@ US$37.9633.7% of flowCommon StockSEC:0001209191-23-048491:0
305 shares@ US$48.202.1% of flowCommon StockSEC:0001209191-23-038885:0
4,216 shares0Common StockSEC:0001714899-23-000094:0
2,663 shares0Common StockSEC:0001209191-23-016039:0
295 shares@ US$54.780.0006% mcap3.8% of flowCommon StockSEC:0001209191-22-038774:0
2,713 shares@ US$66.620.0065% mcap39.9% of flowCommon StockSEC:0001209191-22-015830:0
6,869 shares0Common StockSEC:0001714899-22-000024:0
303 shares@ US$81.144.1% of flowCommon StockSEC:0001209191-21-060760:0
375 shares@ US$91.535.6% of flowCommon StockSEC:0001209191-21-045972:0
437 shares@ US$94.636.7% of flowCommon StockSEC:0001209191-21-042812:0
307 shares@ US$113.685.6% of flowCommon StockSEC:0001209191-21-031378:0
17 of 17 declarations
